327 related articles for article (PubMed ID: 30122922)
1. Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential
Amara RO; Ramadan AA; El-Moslemany RM; Eissa MM; El-Azzouni MZ; El-Khordagui LK
Int J Nanomedicine; 2018; 13():4493-4505. PubMed ID: 30122922
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
Acta Trop; 2020 Dec; 212():105714. PubMed ID: 32950482
[TBL] [Abstract][Full Text] [Related]
3. Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni.
El-Moslemany RM; Eissa MM; Ramadan AA; El-Khordagui LK; El-Azzouni MZ
Acta Trop; 2016 Jul; 159():142-8. PubMed ID: 27039667
[TBL] [Abstract][Full Text] [Related]
4. Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study.
Eissa MM; El-Moslemany RM; Ramadan AA; Amer EI; El-Azzouni MZ; El-Khordagui LK
PLoS One; 2015; 10(11):e0141788. PubMed ID: 26574746
[TBL] [Abstract][Full Text] [Related]
5. Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni.
Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
Parasit Vectors; 2020 Sep; 13(1):474. PubMed ID: 32933556
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model.
Abla N; Keiser J; Vargas M; Reimers N; Haas H; Spangenberg T
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005942. PubMed ID: 28934207
[TBL] [Abstract][Full Text] [Related]
7. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.
Bustinduy AL; Waterhouse D; de Sousa-Figueiredo JC; Roberts SA; Atuhaire A; Van Dam GJ; Corstjens PL; Scott JT; Stanton MC; Kabatereine NB; Ward S; Hope WW; Stothard JR
mBio; 2016 Aug; 7(4):. PubMed ID: 27507822
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier.
Tawfeek GM; Baki MHA; Ibrahim AN; Mostafa MAH; Fathy MM; Diab MSEDM
Parasitol Res; 2019 Dec; 118(12):3519-3533. PubMed ID: 31673833
[TBL] [Abstract][Full Text] [Related]
10. A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection.
Radwan A; El-Lakkany NM; William S; El-Feky GS; Al-Shorbagy MY; Saleh S; Botros S
Parasit Vectors; 2019 Jun; 12(1):304. PubMed ID: 31208446
[TBL] [Abstract][Full Text] [Related]
11. Schistosoma japonicum and S. mansoni: ultrastructural damage in the tegument and reproductive organs after treatment with levo- and dextro-praziquantel.
Irie Y; Utsunomiya H; Tanaka M; Ohmae H; Nara T; Yasuraoka K
Am J Trop Med Hyg; 1989 Aug; 41(2):204-11. PubMed ID: 2505625
[TBL] [Abstract][Full Text] [Related]
12. Niosomes for enhanced activity of praziquantel against Schistosoma mansoni: in vivo and in vitro evaluation.
Zoghroban HS; El-Kowrany SI; Aboul Asaad IA; El Maghraby GM; El-Nouby KA; Abd Elazeem MA
Parasitol Res; 2019 Jan; 118(1):219-234. PubMed ID: 30421348
[TBL] [Abstract][Full Text] [Related]
13. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
[TBL] [Abstract][Full Text] [Related]
14. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni.
el-Lakkany NM; el-Din SH; Sabra AN; Hammam OA
Mem Inst Oswaldo Cruz; 2011 Nov; 106(7):814-22. PubMed ID: 22124553
[TBL] [Abstract][Full Text] [Related]
16. Praziquantel in a clay nanoformulation shows more bioavailability and higher efficacy against murine Schistosoma mansoni infection.
El-Feky GS; Mohamed WS; Nasr HE; El-Lakkany NM; Seif El-Din SH; Botros SS
Antimicrob Agents Chemother; 2015; 59(6):3501-8. PubMed ID: 25845870
[TBL] [Abstract][Full Text] [Related]
17. Improvement of the oral praziquantel anthelmintic effect by cyclodextrin complexation.
de Jesus MB; Pinto Lde M; Fraceto LF; Magalhães LA; Zanotti-Magalhães EM; de Paula E
J Drug Target; 2010 Jan; 18(1):21-6. PubMed ID: 19624246
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability and in vivo efficacy of a praziquantel-polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice.
El-Lakkany N; Seif El-Din SH; Heikal L
Eur J Drug Metab Pharmacokinet; 2012 Dec; 37(4):289-99. PubMed ID: 22460595
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy and bioavailability of different praziquantel brands.
Botros S; El-Lakkany N; Seif el-Din SH; Sabra AN; Ibrahim M
Exp Parasitol; 2011 Feb; 127(2):515-21. PubMed ID: 21044626
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment.
de Souza AL; Andreani T; de Oliveira RN; Kiill CP; dos Santos FK; Allegretti SM; Chaud MV; Souto EB; Silva AM; Gremião MP
Int J Pharm; 2014 Mar; 463(1):31-7. PubMed ID: 24370839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]